164 related articles for article (PubMed ID: 28053596)
1. Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway.
Liu B; Yan S; Qu L; Zhu J
Cancer Cell Int; 2017; 17():1. PubMed ID: 28053596
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
Liu B; Shi ZL; Feng J; Tao HM
Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 inhibitors induce anoikis in osteosarcoma via PI3K/Akt pathway.
Liu B; Qu L; Yang Z; Tao H
Med Hypotheses; 2012 Jul; 79(1):98-100. PubMed ID: 22546756
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib Down-Regulates the Hypoxia-Induced Expression of HIF-1α and VEGF Through the PI3K/AKT Pathway in Retinal Pigment Epithelial Cells.
Sun YZ; Cai N; Liu NN
Cell Physiol Biochem; 2017; 44(4):1640-1650. PubMed ID: 29216640
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H₂₂ murine hepatocarcinoma model.
Sui W; Zhang Y; Wang Z; Wang Z; Jia Q; Wu L; Zhang W
Oncol Rep; 2014 May; 31(5):2252-60. PubMed ID: 24647425
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib inhibits β-catenin-dependent survival of the human osteosarcoma MG-63 cell line.
Xia JJ; Pei LB; Zhuang JP; Ji Y; Xu GP; Zhang ZP; Li N; Yan JL
J Int Med Res; 2010; 38(4):1294-304. PubMed ID: 20926002
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib induces anoikis in human colon carcinoma cells associated with the deregulation of focal adhesions and nuclear translocation of p130Cas.
Casanova I; Parreño M; Farré L; Guerrero S; Céspedes MV; Pavon MA; Sancho FJ; Marcuello E; Trias M; Mangues R
Int J Cancer; 2006 May; 118(10):2381-9. PubMed ID: 16353145
[TBL] [Abstract][Full Text] [Related]
8. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1.
Arunasree KM; Roy KR; Anilkumar K; Aparna A; Reddy GV; Reddanna P
Leuk Res; 2008 Jun; 32(6):855-64. PubMed ID: 18083230
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase.
Kim SH; Kim SH; Song YC; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():635-41. PubMed ID: 19723114
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
[TBL] [Abstract][Full Text] [Related]
11. TWIST interacts with β-catenin signaling on osteosarcoma cell survival against cisplatin.
Wu J; Liao Q; He H; Zhong D; Yin K
Mol Carcinog; 2014 Jun; 53(6):440-6. PubMed ID: 23280703
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib inhibits cell growth and modulates the expression of matrix metalloproteinases in human osteosarcoma MG-63 cell line.
Zhou X; Shi X; Ren K; Fan GT; Wu SJ; Zhao JN
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4087-97. PubMed ID: 26592832
[TBL] [Abstract][Full Text] [Related]
13. Effect of combined cyclooxygenase-2 and matrix metalloproteinase inhibition on human sarcoma xenografts.
Dickens DS; Cripe TP
J Pediatr Hematol Oncol; 2003 Sep; 25(9):709-14. PubMed ID: 12972806
[TBL] [Abstract][Full Text] [Related]
14. Activated PI3K/Akt/COX-2 pathway induces resistance to radiation in human cervical cancer HeLa cells.
Xia S; Zhao Y; Yu S; Zhang M
Cancer Biother Radiopharm; 2010 Jun; 25(3):317-23. PubMed ID: 20578837
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib reverts oxaliplatin-induced neuropathic pain through inhibiting PI3K/Akt2 pathway in the mouse dorsal root ganglion.
Jiang SP; Zhang ZD; Kang LM; Wang QH; Zhang L; Chen HP
Exp Neurol; 2016 Jan; 275 Pt 1():11-6. PubMed ID: 26546510
[TBL] [Abstract][Full Text] [Related]
16. Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cells.
Suh YJ; Chada S; McKenzie T; Liu Y; Swisher SG; Lucci A; Hunt KK
Surgery; 2005 Sep; 138(3):422-30. PubMed ID: 16213894
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib antagonizes the cytotoxicity of cisplatin in human esophageal squamous cell carcinoma cells by reducing intracellular cisplatin accumulation.
Yu L; Chen M; Li Z; Wen J; Fu J; Guo D; Jiang Y; Wu S; Cho CH; Liu S
Mol Pharmacol; 2011 Mar; 79(3):608-17. PubMed ID: 21177414
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F
J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
[TBL] [Abstract][Full Text] [Related]
19. Interaction between celecoxib and docetaxel or cisplatin in human cell lines of ovarian cancer and colon cancer is independent of COX-2 expression levels.
Bijman MN; Hermelink CA; van Berkel MP; Laan AC; Janmaat ML; Peters GJ; Boven E
Biochem Pharmacol; 2008 Jan; 75(2):427-37. PubMed ID: 17936723
[TBL] [Abstract][Full Text] [Related]
20. High expression of ID1 facilitates metastasis in human osteosarcoma by regulating the sensitivity of anoikis via PI3K/AKT depended suppression of the intrinsic apoptotic signaling pathway.
Zhao GS; Zhang Q; Cao Y; Wang Y; Lv YF; Zhang ZS; Zhang Y; Tan QL; Chang Y; Quan ZX; Jiang DM; Guo QN
Am J Transl Res; 2019; 11(4):2117-2139. PubMed ID: 31105823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
